Chief Project Officer
Dr. Christophe Reymond is responsible for coordinating project-related activities within VCLS. As member of the Executive team, he focuses on the adequate and timely provision of deliverables to our clients, and its implementation throughout the project realization process. He oversees the consulting team as a whole, fosters team work, and encourages cross-fertilization to ensure the quality of the content of deliverables as well as the delivery of services in line with our clients’ expectations.
Dr. Reymond’s broad expertise includes strategic planning, people and process management. His scientific knowledge and Biotech experience allows him to understand the needs of clients throughout the development path of their drug product(s).
Dr. Reymond has over 20 years experience as CSO in Biotech companies. As Founder and Director, he contributed to the development of start-ups as well as accompanied their development through milestones achievements and financing rounds. His managerial experience included supervision of clinical trials and related interactions with regulatory authorities.
Previously, Dr. Reymond acted as professor at the University of Lausanne medical School while leading a research group in developmental biology. Before, he conducted a research group on oncogenes at the Swiss cancer research institute (ISREC). His molecular biology training was acquired through a thesis at the University of Geneva and a postdoctoral stay at the University of California San Diego, USA.
Dr. Reymond has published over 40 original articles in international peer-reviewed journals, reviews and book chapters covering various scientific aspects in immunology, developmental biology and innovative technologies. Dr. Reymond is based in our Switzerland office.